Fineline Cube

Follow:
14409 Articles
Imugene and JW Therapeutics Partner to Evaluate onCARlytics CAR‑T Combination for Advanced Solid Tumors
CompanyDeals

Imugene and JW Therapeutics Partner to Evaluate onCARlytics CAR‑T Combination for Advanced Solid Tumors

Humanwell Launches RMB250M Ruicheng Venture Fund for Health Tech
CompanyDeals

Humanwell Launches RMB250M Ruicheng Venture Fund for Health Tech

iRegene's NouvNeu004 Wins FDA Special Exemption for MSA Cell Therapy
CompanyDrug

iRegene’s NouvNeu004 Wins FDA Special Exemption for MSA Cell Therapy

Proviva's PTX-912 PD-1 IL-2 Fusion Gets USD 30M Series A+ Boost
CompanyDeals

Proviva’s PTX-912 PD-1 IL-2 Fusion Gets USD 30M Series A+ Boost

Pfizer-Astellas' PADCEV Wins FDA Approval for Perioperative Bladder Cancer
CompanyDrug

Pfizer-Astellas’ PADCEV Wins FDA Approval for Perioperative Bladder Cancer

GenSci's GenSci142 Wins NMPA Nod for Bacterial Vaginosis Clinical Trials
CompanyDrug

GenSci’s GenSci142 Wins NMPA Nod for Bacterial Vaginosis Clinical Trials

Jiuzhou Pharmaceutical Wins Tentative FDA Approval for Generic Janumet XR
CompanyDrug

Jiuzhou Pharmaceutical Wins Tentative FDA Approval for Generic Janumet XR

Hengrui's Ivarmacitinib Wins NMPA Nod for Vitiligo Clinical Trials
CompanyDrug

Hengrui’s Ivarmacitinib Wins NMPA Nod for Vitiligo Clinical Trials

Juventas CAR-T Wins Second China Approval for Lymphoma, Expands Hematology Franchise
CompanyDrug

Juventas CAR-T Wins Second China Approval for Lymphoma, Expands Hematology Franchise

Innovent's Picankibart Wins NMPA Approval for Psoriasis as IL-23p19 Inhibitor
CompanyDrug

Innovent’s Picankibart Wins NMPA Approval for Psoriasis as IL-23p19 Inhibitor

Trulive Medical Closes Series C, Raising Over RMB 100M for Cardiovascular Innovation
CompanyDeals

Trulive Medical Closes Series C, Raising Over RMB 100M for Cardiovascular Innovation

Boan Biotech's Boyoujing Aflibercept Wins NMPA Approval for Retinal Diseases
CompanyDrug

Boan Biotech’s Boyoujing Aflibercept Wins NMPA Approval for Retinal Diseases